Skip to main content
. 2019 Dec 2;9(2):586–594. doi: 10.1002/cam4.2749

Table 2.

Perioperative outcomes for LPN and RPN after propensity score matching

  LPN (n = 58) RPN (n = 58) P value
Surgical approach (retroperitoneal), n (%) 34 (58.6) 38 (65.5) .444
Operating time, min, mean (SD) 219.1 (33.0) 198.8 (65.9) .040
Estimated blood loss, mL, median (IQR) 200 (100‐300) 160 (100‐212.5) .405
Warm ischemia time, min, mean (SD) 24.2 (4.5) 22.4 (3.6) .023
Transfusion, n (%) 11 (19.0) 5 (8.6) .106
Conversion, n (%) 5 (8.6) 2 (3.4) .242
To open surgery 2 (3.4) 0 .496
To radical surgery 4 (6.9) 2 (3.4) .402
Postoperative hospital stay, days, median (IQR) 9 (7‐10.5) 7.5 (6‐9) .023
Postoperative complications, n (%) 17 (29.3) 12 (20.7) .284
Low grade (Clavien‐Dindo I–II), n (%) 13 (22.4) 9 (15.5) .343
High grade (Clavien‐Dindo III–IV), n (%) 4 (6.9) 3 (5.2) .697
Pathologic stage     .701
pT1b, n (%) 39 (67.2) 44 (75.9)  
pT2, n (%) 2 (3.4) 1 (1.7)  
pT3a, n (%) 5 (8.6) 4 (6.9)  
Fuhrman grade     .741
Low (≤2), n (%) 31 (53.4) 34 (58.6)  
High (≥3), n (%) 7 (12.1) 5 (8.6)  
Not specified, n (%) 8 (13.8) 10 (17.2)  
Histologic subtype     .469
Benign, n (%) 12 (20.7) 9 (15.5)  
Malignant, n (%) 46 (79.3) 49 (84.5)  
Positive surgical margin, n (%) 1 (1.7) 2 (3.4) 1.000
eGFR within postoperative 1 wk, mL/min, mean (SD) 73.2 (18.0) 73.9 (15.4) .805
eGFR decrease in baseline, mL/min, mean (SD) −15.4 (3.4) −14.8 (3.5) .358
Last follow‐up eGFR, mL/min, mean (SD) 77.2 (21.1) 80.8 (14.9) .293
eGFR decrease in baseline, mL/min, mean (SD) −11.3 (13.0) −7.9 (6.3) .077
De novo CKD at last follow‐up, n (%) 11 (19.0) 4 (6.9) .053

Bold indicates statistical significance value (P < 0.05)

Abbreviations: CKD: chronic kidney disease; IQR: inter‐quartile range; SD: standard deviation.